Week 1: Overview, Cognition, Mood, Affect Flashcards
drug interactions: additive effects
-2 drugs with similar actions sum their effects
-can be desireable or undesirable
ie, hydralazine + nitroglycerin= > hypotension
(requires caution and patient knowledge)
beta blocker+ diuretic=
drug interactions: synergism or potentiation
- two drugs with different mechanisms of action produce greater effects (1+1=3)
- ie, codeine+ASA= >pain relief
ampicillin + sulbactam= >therapeutic effect
drug interactions: drug interference
one drug increases or decreases the metabolism or excretion of another
-ie, warfarin, barbituates and cimetidine affect metabolism of many drugs
probenicid slows renal excretion of penicillin
drug interaction: displacement
two drugs compete for binding sites on plasma proteins (i.e., albumin)
ie, anticoagulants & anti- inflamatory = > risk of bleeding
drug interaction: antagonism
- effects of two drugs that cancel each other (1+1=0)
- basis for antidotes to toxic effects of another drug or chemical
ie, naloxone (narcan) prevents opiates from binding to CNS receptor sites (caution not to push Narcan all at once)
drug interaction: incompatibility
- interaction of 2 drugs interferes with action of at least one drug
- check resource (epocrates, micromedex or pharmacist before mixing IV drugs or in syringe)
- basis for drugs that bind/ inactivate another toxic drug in the GI tract
- ie, magnesium in antacids + tetracycline= may impair absorption of tetracycline
- mixing different types of IV meds in the same tubing can cause crystallized drug and line occlusion
Phases of drug action
- pharmaceutics
- pharmcokinetics
- pharmacodynamics
pharmaceutics
drug becomes a solution so that it can cross the biologic membrane
SUBCU, IM, IV DRUGS DO NOT GO THROUGH A PHARMACEUTIC PHASE
pharmcokinetics
absorption
distribution- protein binding
metabolism or biotransformation
excretion or elimination
pharmcokinetics: absorption of oral meds
first pass effect
bioavailability
first pass effect is when the drug passes through the ___ before entering ___ ____. ___ and ___ barriers in GI environ
liver
systemic circulation
chemical
biological
____ is the ___ of drug that reaches ___ ____. in ____ it is always __ 100%. in ___ drugs it is usually ____
bioavailability percent systemic circulation PO IV 100% (no first pass effect)
___ ____ ____ affects _____
first pass metabolism
bioavailability
distribution is the process by which drug becomes ___ __ ___ ___ & _____
available
to
body fluid
tissues
the ___ ___ portion is ___ in ___ ___ ___ drugs
bound drug
inactive
plasma protein bound
a drug is high bound when ___ than ___%
greater than 89%